Wednesday November 25 2009 | Biotechnology feed | All feeds
|
|
AGY Therapeutics
Download detailed PDF Members: AGY Therapeutics has one focus: the discovery, development and commercialization of breakthrough treatments for diseases of the central nervous system. AGY has a pipeline of novel CNS therapeutic programs in the clinic and in preclinical development to meet major unmet medical needs. AGY built its pipeline using its unique, proprietary platform for functional gene discovery and mapping out specific pathways underlying central nervous system diseases. By harnessing these capabilities, AGY identified potential target proteins that can be modulated to block the progression of disease. This is paving the way for novel CNS therapeutics and future growth for AGY.
This page has been viewed 504 times since April 2007, the link to the organisation's website has been followed 137 times Recent Search Terms used to find this page: Agy Therapeutics | AGY THERAPEUTICS | agy ther | agy therapeutics | AGY Therapeutics | AGY Terapeutics | . Search for more companies in South San Francisco Search for more companies in California This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for AGY Therapeutics | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|